Literature DB >> 17855419

Accurate prediction of deleterious protein kinase polymorphisms.

Ali Torkamani1, Nicholas J Schork.   

Abstract

MOTIVATION: Contemporary, high-throughput sequencing efforts have identified a rich source of naturally occurring single nucleotide polymorphisms (SNPs), a subset of which occur in the coding region of genes and result in a change in the encoded amino acid sequence (non-synonymous coding SNPs or 'nsSNPs'). It is hypothesized that a subset of these nsSNPs may underlie common human disease. Testing all these polymorphisms for disease association would be time consuming and expensive. Thus, computational methods have been developed to both prioritize candidate nsSNPs and make sense of their likely molecular physiologic impact.
RESULTS: We have developed a method to prioritize nsSNPs and have applied it to the human protein kinase gene family. The results of our analyses provide high quality predictions and outperform available whole genome prediction methods (74% versus 83% prediction accuracy). Our analyses and methods consider both DNA sequence conservation, which most traditional methods are based on, as well unique structural and functional features of kinases. We provide a ranked list of common kinase nsSNPs that have a higher probability of impacting human disease based on our analyses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855419     DOI: 10.1093/bioinformatics/btm437

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  30 in total

Review 1.  Annotating individual human genomes.

Authors:  Ali Torkamani; Ashley A Scott-Van Zeeland; Eric J Topol; Nicholas J Schork
Journal:  Genomics       Date:  2011-08-02       Impact factor: 5.736

2.  Gene-specific features enhance interpretation of mutational impact on acid α-glucosidase enzyme activity.

Authors:  Aashish N Adhikari
Journal:  Hum Mutat       Date:  2019-08-07       Impact factor: 4.878

3.  Computational modeling of structurally conserved cancer mutations in the RET and MET kinases: the impact on protein structure, dynamics, and stability.

Authors:  Anshuman Dixit; Ali Torkamani; Nicholas J Schork; Gennady Verkhivker
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

4.  Predicting functional regulatory polymorphisms.

Authors:  Ali Torkamani; Nicholas J Schork
Journal:  Bioinformatics       Date:  2008-06-18       Impact factor: 6.937

5.  Congenital disease SNPs target lineage specific structural elements in protein kinases.

Authors:  Ali Torkamani; Natarajan Kannan; Susan S Taylor; Nicholas J Schork
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-25       Impact factor: 11.205

Review 6.  Cancer driver mutations in protein kinase genes.

Authors:  Ali Torkamani; Gennady Verkhivker; Nicholas J Schork
Journal:  Cancer Lett       Date:  2008-12-10       Impact factor: 8.679

7.  Automated inference of molecular mechanisms of disease from amino acid substitutions.

Authors:  Biao Li; Vidhya G Krishnan; Matthew E Mort; Fuxiao Xin; Kishore K Kamati; David N Cooper; Sean D Mooney; Predrag Radivojac
Journal:  Bioinformatics       Date:  2009-09-03       Impact factor: 6.937

8.  An integrated approach to the interpretation of single amino acid polymorphisms within the framework of CATH and Gene3D.

Authors:  Jose M G Izarzugaza; Anja Baresic; Lisa E M McMillan; Corin Yeats; Andrew B Clegg; Christine A Orengo; Andrew C R Martin; Alfonso Valencia
Journal:  BMC Bioinformatics       Date:  2009-08-27       Impact factor: 3.169

9.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

Review 10.  Analytical methods for inferring functional effects of single base pair substitutions in human cancers.

Authors:  William Lee; Peng Yue; Zemin Zhang
Journal:  Hum Genet       Date:  2009-05-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.